Last 7 days
-13.9%
Last 30 days
-8.6%
Last 90 days
0.4%
Trailing 12 Months
-26.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MSFT | 2.1T | 204.1B | -1.92% | -6.89% | 30.81 | 10.18 | 10.38% | -5.25% |
ORCL | 239.2B | 46.1B | -7.20% | 4.35% | 27.2 | 5.19 | 11.29% | -14.28% |
CRM | 186.1B | 31.4B | 6.91% | -6.75% | 894.86 | 5.94 | 19.41% | -85.60% |
ADBE | 170.8B | 17.6B | -11.04% | -20.88% | 35.91 | 9.7 | 11.54% | -1.37% |
ZM | 20.5B | 4.4B | -7.13% | -28.23% | 197.36 | 4.66 | 7.15% | -92.46% |
AZPN | 12.1B | - | -3.12% | 49.09% | 44.35 | 17.39 | - | - |
MID-CAP | ||||||||
PLAN | 9.6B | 631.5M | -1.97% | 16.85% | -45.68 | 15.19 | 33.30% | -26.60% |
MANH | 8.9B | 767.1M | -2.98% | 9.04% | 69.2 | 11.63 | 15.59% | 16.73% |
GWRE | 6.5B | 869.9M | 3.14% | -9.62% | -33 | 7.53 | 13.87% | -103.37% |
APPN | 3.0B | 468.0M | 2.00% | -15.48% | -19.64 | 6.33 | 26.74% | -70.26% |
PING | 2.4B | 308.3M | 1.17% | 7.67% | -23.16 | 7.93 | 13.75% | -237.98% |
SMALL-CAP | ||||||||
ZUO | 1.2B | 383.7M | 4.07% | -32.35% | -9.91 | 3.24 | 14.43% | -50.89% |
YEXT | 1.2B | 399.9M | 30.95% | 57.36% | -14.32 | 2.91 | 4.73% | 8.15% |
UPLD | 152.1M | 317.3M | -43.48% | -70.17% | -2.22 | 0.48 | 5.06% | -17.52% |
Income Statement (Last 12 Months) | (In Thousands) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 4.3% | 2,437,167 | 2,337,167 | 2,226,827 | 2,107,213 | 1,957,283 |
Gross Profit | 4.7% | 1,907,051 | 1,820,618 | 1,733,202 | 1,640,762 | 1,520,706 |
Operating Expenses | 5.8% | 2,019,976 | 1,909,470 | 1,803,575 | 1,702,646 | 1,582,309 |
S&GA Expenses | 3.2% | 1,237,479 | 1,199,315 | 1,138,105 | 1,076,527 | 999,006 |
R&D Expenses | 2.9% | 465,385 | 452,054 | 420,173 | 393,362 | 362,805 |
EBITDA | -164.9% | -33,647 | -12,700 | 3,530 | - | - |
EBITDA Margin | -154.1% | -0.01* | -0.01* | 0.00* | - | - |
Earnings Before Taxes | -21.8% | -124,727 | -102,443 | -86,067 | -66,914 | -101,051 |
EBT Margin | -16.8% | -0.05* | -0.04* | -0.04* | - | - |
Interest Expenses | -0.5% | 6,354 | 6,383 | 6,420 | 6,443 | 12,612 |
Net Income | -22.3% | -132,762 | -108,572 | -88,995 | -69,976 | -111,943 |
Net Income Margin | -17.3% | -0.05* | -0.05* | -0.04* | - | - |
Free Cahsflow | -12.3% | 386,434 | 440,391 | 496,647 | - | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 2.4% | 2,732 | 2,667 | 2,574 | 2,541 | 2,411 |
Current Assets | 4.0% | 1,480 | 1,423 | 1,363 | 1,320 | 1,207 |
Cash Equivalents | -0.7% | 633 | 637 | 638 | 509 | 504 |
Net PPE | 5.3% | 196 | 186 | 184 | 185 | 178 |
Goodwill | -0.3% | 352 | 353 | 354 | 355 | 355 |
Liabilities | 0.1% | 2,263 | 2,260 | 2,225 | 2,266 | 2,171 |
Current Liabilities | 3.4% | 1,450 | 1,402 | 1,344 | 1,372 | 1,260 |
Shareholder's Equity | 15.1% | 469 | 407 | 349 | 276 | 240 |
Retained Earnings | -4.4% | -1,603 | -1,535 | -1,465 | -1,438 | -1,407 |
Additional Paid-In Capital | 7.1% | 2,108 | 1,969 | 1,835 | 1,720 | 1,651 |
Shares Outstanding | 0.1% | 201 | 201 | 200 | 199 | 198 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -10.4% | 457 | 510 | 567 | 506 | 481 |
Share Based Compensation | 6.5% | 511 | 479 | 438 | 409 | 374 |
Cashflow From Investing | 25.0% | -152 | -203 | -154 | -162 | -176 |
Cashflow From Financing | 9.7% | -156 | -173 | -280 | -394 | -177 |
Buy Backs | 152.0% | 126 | 50.00 | 0.00 | - | - |
75.2%
45.0%
41.9%
Y-axis is the maximum loss one would have experienced if Docusign was unfortunately bought at previous high price.
-9.9%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -14.01 | -99,921 | 814,079 | 0.02% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -75.98 | -3,733,420 | 1,237,580 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 837 | 6,860,000 | 7,646,000 | 0.04% |
2023-03-02 | OLIVER LAGORE VANVALIN INVESTMENT GROUP | reduced | -6.25 | -169 | 831 | -% |
2023-03-01 | Lakewood Asset Management LLC | new | - | 2,000 | 2,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 0.35 | -18,754,700 | 4,763,290 | 0.01% |
2023-02-27 | Parallax Volatility Advisers, L.P. | reduced | -92.44 | -34,233,200 | 2,908,830 | -% |
2023-02-24 | BBJS FINANCIAL ADVISORS, LLC | new | - | 618,598 | 618,598 | 0.28% |
2023-02-24 | Garde Capital, Inc. | new | - | 606,000 | 606,000 | 0.07% |
2023-02-24 | NATIXIS | reduced | -61.69 | -22,509,200 | 14,821,800 | 0.08% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 0.4% | 714,175 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.48% | 19,056,614 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 6.7% | 13,391,517 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 5.3% | 10,555,002 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 7.27% | 14,391,194 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 5.9% | 11,588,144 | SC 13G/A | |
Feb 16, 2021 | price t rowe associates inc /md/ | 5.3% | 10,033,880 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.72% | 16,276,093 | SC 13G/A | |
Feb 05, 2021 | blackrock inc. | 6.4% | 11,961,898 | SC 13G | |
Sep 10, 2020 | price t rowe associates inc /md/ | 7.8% | 14,611,904 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 2.80 -95.10% | 5.94 -89.61% | 15.95 -72.11% | 35.20 -38.44% | 65.03 13.73% |
Current Inflation | 2.56 -95.52% | 5.33 -90.68% | 13.95 -75.60% | 30.26 -47.08% | 55.43 -3.06% |
Very High Inflation | 2.26 -96.05% | 4.59 -91.97% | 11.60 -79.71% | 24.58 -57.01% | 44.48 -22.21% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 17, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 16, 2023 | 4 | Insider Trading | |
Mar 16, 2023 | 4 | Insider Trading | |
Mar 16, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 3 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 13, 2023 | 4 | Insider Trading | |
Mar 10, 2023 | 8-K | Current Report | |
Mar 09, 2023 | 8-K | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | Wilderotter Mary Agnes | sold (taxes) | - | - | -81.00 | - |
2023-03-03 | Salem Enrique T | acquired | - | - | 671 | - |
2023-03-03 | Wilderotter Mary Agnes | acquired | - | - | 671 | - |
2023-03-03 | Briggs Teresa | acquired | - | - | 671 | - |
2023-03-03 | Hayes Cain A | acquired | - | - | 671 | - |
2023-03-03 | Solvik Peter | acquired | - | - | 671 | - |
2023-03-03 | Irving Blake | acquired | - | - | 671 | - |
2023-03-03 | BEER JAMES A | acquired | - | - | 671 | - |
2023-03-01 | Hayes Cain A | acquired | - | - | 154 | - |
2023-02-28 | BEER JAMES A | acquired | - | - | 155 | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Oct. 31, 2022 | Oct. 31, 2021 | Oct. 31, 2022 | Oct. 31, 2021 | |
Revenue: | ||||
Total revenue | $ 645,463 | $ 545,463 | $ 1,856,339 | $ 1,526,385 |
Cost of revenue: | ||||
Total cost of revenue | 129,542 | 115,975 | 398,662 | 334,997 |
Gross profit | 515,921 | 429,488 | 1,457,677 | 1,191,388 |
Operating expenses: | ||||
Sales and marketing | 313,783 | 275,619 | 938,062 | 777,110 |
Research and development | 115,934 | 102,603 | 354,693 | 282,670 |
General and administrative | 85,553 | 54,624 | 224,587 | 168,314 |
Restructuring and other related charges | 28,082 | 0 | 28,082 | 0 |
Total operating expenses | 543,352 | 432,846 | 1,545,424 | 1,228,094 |
Loss from operations | (27,431) | (3,358) | (87,747) | (36,706) |
Interest expense | (1,456) | (1,485) | (4,737) | (4,826) |
Interest income and other income (expense), net | 820 | (940) | (2,827) | 4,034 |
Loss before provision for (benefit from) income taxes | (28,067) | (5,783) | (95,311) | (37,498) |
Provision for (benefit from) income taxes | 1,799 | (107) | 7,006 | 2,033 |
Net loss | $ (29,866) | $ (5,676) | $ (102,317) | $ (39,531) |
Net loss per share attributable to common stockholders, basic (in usd per share) | $ (0.15) | $ (0.03) | $ (0.51) | $ (0.20) |
Net loss per share attributable to common stockholders, diluted (in usd per share) | $ (0.15) | $ (0.03) | $ (0.51) | $ (0.20) |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic (in shares) | 201,393 | 197,597 | 200,569 | 195,996 |
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted (in shares) | 201,393 | 197,597 | 200,569 | 195,996 |
Other comprehensive loss: | ||||
Foreign currency translation loss, net of tax | $ (6,787) | $ (4,720) | $ (23,641) | $ (6,142) |
Unrealized losses on investments, net of tax | (3,011) | (415) | (5,794) | (711) |
Other comprehensive loss | (9,798) | (5,135) | (29,435) | (6,853) |
Comprehensive loss | (39,664) | (10,811) | (131,752) | (46,384) |
Stock-based compensation expense included in costs and expenses | ||||
Stock-based compensation expense | 392,765 | 290,536 | ||
Sales and marketing | ||||
Stock-based compensation expense included in costs and expenses | ||||
Stock-based compensation expense | 57,925 | 49,663 | 166,574 | 134,720 |
Research and development | ||||
Stock-based compensation expense included in costs and expenses | ||||
Stock-based compensation expense | 35,506 | 30,074 | 108,689 | 76,811 |
General and administrative | ||||
Stock-based compensation expense included in costs and expenses | ||||
Stock-based compensation expense | 23,384 | 14,338 | 58,314 | 38,103 |
Restructuring and other related charges | ||||
Stock-based compensation expense included in costs and expenses | ||||
Stock-based compensation expense | 5,590 | 0 | 5,590 | 0 |
Subscription | ||||
Revenue: | ||||
Total revenue | 624,055 | 528,573 | 1,798,500 | 1,473,266 |
Cost of revenue: | ||||
Total cost of revenue | 102,524 | 84,579 | 315,614 | 247,105 |
Subscription | Cost of revenue | ||||
Stock-based compensation expense included in costs and expenses | ||||
Stock-based compensation expense | 11,665 | 8,095 | 35,272 | 21,652 |
Professional services and other | ||||
Revenue: | ||||
Total revenue | 21,408 | 16,890 | 57,839 | 53,119 |
Cost of revenue: | ||||
Total cost of revenue | 27,018 | 31,396 | 83,048 | 87,892 |
Professional services and other | Cost of revenue | ||||
Stock-based compensation expense included in costs and expenses | ||||
Stock-based compensation expense | $ 6,767 | $ 7,270 | $ 18,327 | $ 19,250 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands | Oct. 31, 2022 | Jan. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 632,620 | $ 509,059 |
Investments—current | 342,730 | 293,763 |
Accounts receivable, net of allowance for doubtful accounts of $5,203 and $5,807 as of October 31, 2022 and January 31, 2022 | 422,612 | 440,950 |
Contract assets—current | 13,609 | 12,588 |
Prepaid expenses and other current assets | 68,814 | 63,236 |
Total current assets | 1,480,385 | 1,319,596 |
Investments—noncurrent | 129,783 | 94,938 |
Property and equipment, net | 196,127 | 184,664 |
Operating lease right-of-use assets | 92,155 | 126,021 |
Goodwill | 352,423 | 355,058 |
Intangible assets, net | 75,232 | 98,816 |
Deferred contract acquisition costs—noncurrent | 329,958 | 311,835 |
Other assets—noncurrent | 75,521 | 50,337 |
Total assets | 2,731,584 | 2,541,265 |
Current liabilities | ||
Accounts payable | 47,176 | 52,804 |
Accrued expenses and other current liabilities | 96,227 | 91,377 |
Accrued compensation | 146,297 | 160,163 |
Convertible senior notes—current | 36,921 | 0 |
Contract liabilities—current | 1,088,197 | 1,029,891 |
Operating lease liabilities—current | 34,713 | 37,404 |
Total current liabilities | 1,449,531 | 1,371,639 |
Convertible senior notes, net—noncurrent | 684,861 | 718,487 |
Contract liabilities—noncurrent | 15,242 | 16,725 |
Operating lease liabilities—noncurrent | 81,237 | 126,340 |
Deferred tax liability—noncurrent | 10,400 | 9,316 |
Other liabilities—noncurrent | 21,807 | 23,255 |
Total liabilities | 2,263,078 | 2,265,762 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity | ||
Preferred stock, $0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of October 31, 2022 and January 31, 2022 | 0 | 0 |
Common stock, $0.0001 par value; 500,000 shares authorized, 201,069 shares outstanding as of October 31, 2022; 500,000 shares authorized, 198,834 shares outstanding as of January 31, 2022 | 20 | 20 |
Treasury stock, at cost: 10 and 7 shares as of October 31, 2022 and January 31, 2022 | (1,785) | (1,532) |
Additional paid-in capital | 2,108,062 | 1,720,013 |
Accumulated other comprehensive loss | (34,244) | (4,809) |
Accumulated deficit | (1,603,547) | (1,438,189) |
Total stockholders’ equity | 468,506 | 275,503 |
Total liabilities and stockholders' equity | $ 2,731,584 | $ 2,541,265 |